Imatinib Mesylate
98%
- Product Code: 110422
Alias:
Imatinib mesylate
CAS:
220127-57-1
Properties:
Soluble in water (200 mg/ml), ethanol (~0.2 mg/ml), DMSO (200 mg/ml), DMF (~10 mg/ml), and methanol (sparingly).
| Molecular Weight: | 589.72 g./mol | Molecular Formula: | C₂₉H₃₁N₇OCH₄O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD04307699 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2~8℃ |
Product Description:
Imatinib Mesylate is primarily used in the treatment of certain types of cancer. It is highly effective in managing chronic myeloid leukemia (CML), where it targets the abnormal BCR-ABL protein produced by the Philadelphia chromosome, inhibiting the growth of cancerous cells. Additionally, it is used to treat gastrointestinal stromal tumors (GISTs) by blocking the activity of the KIT protein, which drives tumor growth. Imatinib Mesylate is also prescribed for patients with acute lymphoblastic leukemia (ALL) who have the Philadelphia chromosome mutation. Its ability to selectively inhibit tyrosine kinases makes it a cornerstone in targeted cancer therapy, significantly improving patient outcomes and survival rates.
Product Specification:
| Test | Specification |
|---|---|
| Purity (%) | 97.5-100 |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿660.00 |
+
-
|
| 5.000 | 10-20 days | ฿1,340.00 |
+
-
|
| 25.000 | 10-20 days | ฿3,460.00 |
+
-
|
| 100.000 | 10-20 days | ฿13,280.00 |
+
-
|
Imatinib Mesylate
Imatinib Mesylate is primarily used in the treatment of certain types of cancer. It is highly effective in managing chronic myeloid leukemia (CML), where it targets the abnormal BCR-ABL protein produced by the Philadelphia chromosome, inhibiting the growth of cancerous cells. Additionally, it is used to treat gastrointestinal stromal tumors (GISTs) by blocking the activity of the KIT protein, which drives tumor growth. Imatinib Mesylate is also prescribed for patients with acute lymphoblastic leukemia (ALL) who have the Philadelphia chromosome mutation. Its ability to selectively inhibit tyrosine kinases makes it a cornerstone in targeted cancer therapy, significantly improving patient outcomes and survival rates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :